Article
Reversible nitrous oxide myelopathy and a polymorphism in the gene encoding 5,10-methylenetetrahydrofolate reductase.
British journal of anaesthesia - 1 Feb 2006
Lacassie H J, Nazar C, Yonish B, Sandoval P, Muir H A, Mellado P
Abstract excerpt
We present a case of a patient who received nitrous oxide on two occasions within a period of 8 weeks and who subsequently developed a diffuse myelopathy, characterized by upper extremity paresis, lower extremity paraplegia and neurogenic bladder. Laboratory testing revealed hyperhomocysteinaemia and low levels of vitamin B(12). Because of this uncommon clinical presentation, we analysed the patient's DNA, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
